TSLA
Tesla
-- 292.980 NVDA
NVIDIA
-- 124.920 MSTR
Strategy
-- 255.430 COIN
Coinbase
-- 215.620 MARA
MARA Holdings
-- 13.920 
Update
$Recursion Pharmaceuticals (RXRX.US)$ Reuters· 9 mins ago
Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class Cdk7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability
Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class Cdk7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
NoNo444 : Let's go 20